zveid fmk (Tocris)
Structured Review
Zveid Fmk, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/zveid+fmk/Fmk/10__1128_slash_jvi__01999___10-65-12-15
Average 93 stars, based on 8 article reviews
Images
Related Articles
Incubation:Article Title: Nuclear Envelope Disruption Involving Host Caspases Plays a Role in the Parvovirus Replication Cycle Article Snippet: Evenly spread GFP-LAP2 HeLa cells grown in -slide eight-well dishes (Ibidi; ibiTreat) were washed in permeabilization buffer (PB) (20 mM HEPES KOH [pH 7.4], 110 mM potassium acetate [KOAc], 5 mM MgOAc, 0.5 mM EGTA, and 250 mM sucrose), permeabilized in PB containing 15 g/ml digitonin for 3 min, and then washed three times in PB for 2 min. Permeabilized cells were then incubated or mock incubated with MVM at a multiplicity of infection (MOI) of 4 PFU/cell in transport buffer (TB) (20 mM HEPES KOH [pH 7.3], 110 mM KOAc, 5 mM NaOAc, 1 mM EGTA, and 2 mM dithiothreitol [DTT]) containing 155-kDa tetramethyl rhodamine isocyanate (TRITC)-labeled dextran (250 g/ml) (Sigma-Aldrich) and visualized immediately on an Olympus Fluoview FV1000 laser scanning microscope at 37°C. .. Where indicated, the caspase inhibitor zVAD-fmk (200 M), zDEVD-fmk (50 M), or Article Title: Nuclear Envelope Disruption Involving Host Caspases Plays a Role in the Parvovirus Replication Cycle Article Snippet: For the phospholipase A2 (PLA2) inhibition experiment, MVM was incubated with 10 M manoalide (Alexis Biochemicals) for 1 h at room temperature with agitation prior to microinjection. .. Where indicated, a 50 mM concentration of the caspase inhibitor benzyloxycarbonylVal-Ala-Asp-fluoromethyl ketone (zVAD-fmk), zDEVD-fmk, or Article Title: Nuclear Envelope Disruption Involving Host Caspases Plays a Role in the Parvovirus Replication Cycle Article Snippet: .. The medium was then replaced, and cells were incubated at 37°C for 2, 15, or 21 h. Where indicated, the caspase inhibitor zVAD-fmk, zDEVD-fmk, or Concentration Assay:Article Title: Nuclear Envelope Disruption Involving Host Caspases Plays a Role in the Parvovirus Replication Cycle Article Snippet: For the phospholipase A2 (PLA2) inhibition experiment, MVM was incubated with 10 M manoalide (Alexis Biochemicals) for 1 h at room temperature with agitation prior to microinjection. .. Where indicated, a 50 mM concentration of the caspase inhibitor benzyloxycarbonylVal-Ala-Asp-fluoromethyl ketone (zVAD-fmk), zDEVD-fmk, or Injection:Article Title: Nuclear Envelope Disruption Involving Host Caspases Plays a Role in the Parvovirus Replication Cycle Article Snippet: For the phospholipase A2 (PLA2) inhibition experiment, MVM was incubated with 10 M manoalide (Alexis Biochemicals) for 1 h at room temperature with agitation prior to microinjection. .. Where indicated, a 50 mM concentration of the caspase inhibitor benzyloxycarbonylVal-Ala-Asp-fluoromethyl ketone (zVAD-fmk), zDEVD-fmk, or Electron Microscopy:Article Title: Nuclear Envelope Disruption Involving Host Caspases Plays a Role in the Parvovirus Replication Cycle Article Snippet: For the phospholipase A2 (PLA2) inhibition experiment, MVM was incubated with 10 M manoalide (Alexis Biochemicals) for 1 h at room temperature with agitation prior to microinjection. .. Where indicated, a 50 mM concentration of the caspase inhibitor benzyloxycarbonylVal-Ala-Asp-fluoromethyl ketone (zVAD-fmk), zDEVD-fmk, or Infection:Article Title: Nuclear Envelope Disruption Involving Host Caspases Plays a Role in the Parvovirus Replication Cycle Article Snippet: .. The medium was then replaced, and cells were incubated at 37°C for 2, 15, or 21 h. Where indicated, the caspase inhibitor zVAD-fmk, zDEVD-fmk, or |

